Jupiter Life Line Hospitals Ltd (JLHL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Jupiter Life Line Hospitals Ltd on NSE and BSE, with an AI summary of each filing.
Q2 FY27 Earnings Conference Call - Transcript
Transcript · 29 Oct 2026, 11:54 pm
Audio Link of Analyst/ Investor Conference Call for Q2 & H1 FY27
Audio / Video · 26 Oct 2026, 8:19 pm
Jupiter Life Line Hospitals Releases Q2 & H1 FY27 Earnings Call Audio Jupiter Life Line Hospitals Limited has made available the audio recording of its analyst and investor conference call held on 26th Oct'26 at 10:00 AM IST. The call discussed the company's financial and operational performance for the quarter and half year ended 30th Sep'26 (Q2 & H1 FY27). The recording is accessible to investors via the company’s official website under compliance with SEBI LODR Regulations.
Investor Presentation for the quarter and half year ended September 30, 2026
Investor Presentation · 23 Oct 2026, 10:31 pm
Jupiter Life Line Hospitals Q2 & H1FY27 Financial and Operational Performance In Q2FY27, Jupiter Life Line Hospitals reported total income of Rs 456.5 cr, up 16.0% YoY and 11.1% QoQ, with EBITDA growing 15.9% YoY to Rs 106.9 cr (23.4% margin) and PAT at Rs 56.4 cr. For H1FY27, total income rose 16.2% YoY to Rs 867.5 cr, while PAT declined 7.4% YoY to Rs 93.9 cr due to initial Dombivli hospital ramp-up losses and higher finance costs. Operational beds reached 1,259 with ARPOB rising to Rs 71,800. Additionally, the board approved acquiring leased land for Pune South for Rs 150 cr.
Sale agreement for the acquisition of land, South Pune.
Others (Uncategorized) · 23 Oct 2026, 10:26 pm
Jupiter Life Line Hospitals Q2 Results, Land Acquisition, and Subsidiary Incorporation Jupiter Life Line Hospitals' board approved entering a sale agreement to acquire ~11,452.07 sq. metres of land in Bibvewadi, Pune for ₹150 Cr from Jairaj Ventures, transitioning its under-development South Pune hospital project from leasehold to freehold. The board also approved incorporating a wholly owned subsidiary, Holitti Private Limited, for healthcare services with ₹1 Lakh capital. For Q2 ended 30th Sep'26, consolidated revenue from operations rose 15.97% YoY to ₹4,564.96 Mn, while net profit declined 1.95% YoY to ₹563.59 Mn with diluted EPS of ₹1.72.
Incorporation of a wholly owned subsidiary of the Company
Others (Uncategorized) · 23 Oct 2026, 10:02 pm
Jupiter Life Line Hospitals Q2 Results, Subsidiary Incorporation, and Land Acquisition Jupiter Life Line Hospitals reported Q2 consolidated revenue of ₹4,564.96 million (vs ₹3,936.29 million YoY) and net profit of ₹563.59 million (vs ₹574.77 million YoY). For H1 ended 30th Sep'26, revenue stood at ₹8,674.79 million with net profit of ₹938.71 million. The board approved incorporating a wholly owned subsidiary, Holitti Private Limited, for healthcare services with ₹1,00,000 paid-up capital. Additionally, the company is entering a ₹150 Crore sale agreement with Jairaj Ventures to acquire ~11,452.07 sq metres of land for its South Pune hospital project.
Outcome of the Board Meeting held on Friday, October 23, 2026
Financial Result · 23 Oct 2026, 9:57 pm
Outcome of the Board Meeting held on Friday, October 23, 2026
Outcome · 23 Oct 2026, 9:48 pm
Outcome of the Board Meeting held on Friday, October 23, 2026
Outcome · 23 Oct 2026, 9:37 pm
Jupiter Life Line Hospitals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 4,565 (+16.0% YoY | +11.1% QoQ) ■ EBITDA: 1,068 (+15.8% YoY | +34.8% QoQ) ■ EBITDA Margin (%): 23.4 (-3 bps YoY | +412 bps QoQ) ■ PAT: 562 (-2.1% YoY | +49.8% QoQ) ■ EPS (INR): 1.72 (-1.7% YoY | +50.9% QoQ)
Jupiter Life Line Hospitals Limited ('JLHL/Company') has entered into hypothecation agreement with HDFC Bank Limited executed on 18/10/2026 for financing the capital expenditure requirement ....
Others (Uncategorized) · 19 Oct 2026, 5:14 pm
Jupiter Life Line Hospitals Secures Rs. 500 Cr Term Loan From HDFC Bank Jupiter Life Line Hospitals Limited executed a hypothecation agreement on 18th Oct'26 with HDFC Bank Limited for a term loan facility of Rs. 500 Cr (including a sublimit of Rs. 300 Cr for LC facility) to finance its capital expenditure requirements. Current outstanding debt under the facility is nil. The facility is secured via an exclusive charge on immovable properties and tangible movable assets of its Dombivli and Pune Baner hospitals, alongside a pari-passu charge on current assets and receivables.
Intimation of Earnings Conference Call - Q2 & H1 FY 27
Intimation · 26 Oct 2026, 10:00 am
Jupiter Life Line Hospitals Schedules Q2 & H1 FY27 Earnings Call Jupiter Life Line Hospitals Limited will host an earnings conference call on 26th Oct'26 at 10:00 AM IST to discuss its operational and financial performance for Q2 & H1 FY27. Managing Director and CEO Dr. Ankit Thakker, alongside the senior management team, will represent the company. Interested investors and analysts can access the call via primary lines (+91 22 6280 1309 / +91 22 7115 8210) or international toll-free numbers for the US, UK, Singapore, and Hong Kong. Pre-registration details are available online.
Jupiter Life Line Hospitals Limited has informed the Exchange about Board Meeting to be held on 23-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 23 Oct 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 23 Oct 2026, 5:30 am
Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Financial ....
Intimation · 23 Oct 2026, 5:30 am
Jupiter Life Line Hospitals Schedules Board Meeting for Q2 Results Jupiter Life Line Hospitals Limited has scheduled its Board of Directors meeting on 23rd Oct'26 to consider, review, and approve the standalone and consolidated unaudited financial results alongside the Limited Review Report for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for designated persons and their immediate relatives remains closed until 48 hours post the declaration of results, per SEBI insider trading regulations.
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure requirements) Regulations 2015.
Intimation · 15 Sept 2026, 10:15 pm
Jupiter Life Line Hospitals to Attend PL Capital Investor Conference Jupiter Life Line Hospitals Limited announced that its officials will attend an in-person Investor Conference organized by PL Capital on 28th Sep'26, from 1:00 PM to 5:00 PM. The company stated that discussions will strictly be based on publicly available information, and no unpublished price-sensitive information (UPSI) will be shared during the interactions.
Q1 FY27 Earnings Conference Call - Transcript
Transcript · 07 Aug 2026, 7:14 pm
Audio Link of Analyst/ Investor Conference Call for Q1 FY27
Audio / Video · 03 Aug 2026, 11:35 pm
Jupiter Life Line Hospitals Posts Q1 FY27 Earnings Call Audio Jupiter Life Line Hospitals (JLHL) has published the audio recording of its analyst and investor conference call held on 3rd Aug'26. The call discussed the company's financial and operational performance for the first quarter ended 30th Jun'26. The audio link is now available on the company's official website as per SEBI disclosure requirements.
Intimation under Regulation 30(5) of the Listing Regulation
Others (Uncategorized) · 31 Jul 2026, 11:58 pm
Jupiter Life Line Hospitals Authorizes CFO to Determine Materiality Jupiter Life Line Hospitals' Board of Directors, in its meeting on Jul 31, '26, authorized CFO Mr. Harshad Purani to determine the materiality of events or information. This authority is in addition to the existing authorization held by Dr. Ankit Thakker, Managing Director & CEO. Ms. Suma Upparatti, Company Secretary, remains authorized to make disclosures to the stock exchanges. This action complies with SEBI's Regulation 30(5) regarding key managerial personnel responsibility for disclosure assessments.
Investor Presentation for the quarter ended June 30, 2026
Investor Presentation · 31 Jul 2026, 11:37 pm
Jupiter Life Line: Q1FY27 Revenue Grows, but New Hospital Costs Pressure Profits Jupiter Life Line Hospitals reported Q1FY27 revenue of ₹411.0 cr, a 16.4% YoY increase, driven by higher patient volumes. EBITDA grew modestly by 1.1% YoY to ₹79.3 cr, as margins contracted to 19.3% from 22.2% last year. This was due to a ₹9.5 cr operational loss from the new Dombivli hospital, higher marketing costs, depreciation, and finance charges for capex. Consequently, PAT declined 14.7% YoY to ₹37.5 cr. ARPOB rose 9.2% YoY to ₹73,500, while occupancy remained steady at 59.6%.
Acquistion of shares
Others (Uncategorized) · 31 Jul 2026, 11:01 pm
Jupiter Life Line Hospitals: Q1FY27 Results, CFO Appointment, and Subsidiary Acquisition Jupiter Life Line Hospitals reported Q1FY27 consolidated net profit of ₹375.1 mn, down 14.7% YoY, on revenue of ₹4,109.8 mn, up 16.4% YoY. Standalone net profit was ₹371.9 mn (-14.1% YoY) on revenue of ₹3,284.9 mn (+18.2% YoY). The board appointed Mr. Harshad Purani as CFO effective 31 Jul'26. Additionally, its subsidiary, Jupiter Hospital Pharmacy, acquired 100% of Sulcus Private Limited for ₹3.78 crore to establish a pharmaceutical manufacturing facility, aiming to reduce costs and improve margins.
Change in Managment
Change in Management · 31 Jul 2026, 10:50 pm
Outcome of Board Meeting dated July 31, 2026
Financial Result · 31 Jul 2026, 10:27 pm
Jupiter Life Line Hospitals: Q1FY27 Results and Strategic Acquisition For Q1FY27 ended Jun 30, ‘26, consolidated PAT declined 14.6% YoY to ₹37.5 Cr on revenue of ₹411.0 Cr, up 16.5% YoY. On a standalone basis, PAT fell 14.1% YoY to ₹37.2 Cr. The board also approved subsidiary JHPPL's 100% acquisition of Sulcus Private Limited for ₹3.78 Cr to establish a pharmaceutical manufacturing facility, aiming for vertical integration and margin improvement. Additionally, Mr. Harshad Purani was appointed as CFO effective Jul 31, ‘26.
Outcome of Board Meeting dated July 31, 2026
Outcome · 31 Jul 2026, 10:15 pm
Jupiter Life Line Hospitals Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Million) ■ Revenue: 4,110 (+16.4% YoY | +6.0% QoQ) ■ EBITDA: 793 (+1.1% YoY | -11.1% QoQ) ■ EBITDA Margin (%): 19.3 (-293 bps YoY | -370 bps QoQ) ■ PAT: 375 (-14.6% YoY | -25.9% QoQ) ■ EPS (INR): 5.72 (-14.5% YoY | -25.3% QoQ)
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Acquisition/ Disposal of Shares · 30 Jul 2026, 6:33 pm
Catalyst Trusteeship Corrects Pledged Holding in Jupiter Life Line Hospitals Catalyst Trusteeship Limited rectified a previous disclosure regarding pledged holdings in Jupiter Life Line Hospitals. A filing on 28-Jul'26 incorrectly stated a pledged holding of 30.67%. The correct figure is 5.11%. The error occurred due to a miscalculation following a stock split that changed the share face value from ₹10 to ₹2. While the number of pledged shares increased post-split from 33,51,950 to 1,67,59,750, the actual percentage of pledged equity remains unchanged at 5.11%. The revised disclosure was filed on 30-Jul'26.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Acquisition/ Disposal of Shares · 29 Jul 2026, 3:41 pm
Jupiter Life Line Hospitals Shares Pledged by Promoter Group Catalyst Trusteeship Limited, acting as a debenture trustee, disclosed the creation of a pledge over shares of Jupiter Life Line Hospitals. On 25 Jun'26, 1,67,59,750 shares, representing 25.56% of the company's total voting capital, were pledged. Following this transaction, the total number of shares encumbered with Catalyst Trusteeship increased to 2,01,11,700, equivalent to 30.67% of Jupiter Life Line Hospitals' total capital. This action was taken for the benefit of debenture holders.
Intimation of Earnings Conference Call - Q1 FY 27
Intimation · 03 Aug 2026, 10:00 am
Jupiter Life Line Hospitals to Hold Q1 FY27 Earnings Call on Aug 3, 2026 Jupiter Life Line Hospitals (JLHL) will host an earnings conference call for investors and analysts on Mon, 3rd Aug'26, at 10:00 AM IST. The call will discuss the operational and financial performance for Q1 FY27. Management, including MD & CEO Dr. Ankit Thakker, will be present. The results will be available on the company's website.